Rheumatic Disorders Drug Market

What is Rheumatic disorders?
Rheumatic disorders are associated with joints tendons, ligaments, bones, and muscles. They are also called as musculoskeletal diseases. The field that studies these types of disorders is called rheumatology. At present, there are more than 200 distinct rheumatic diseases. Among which most common are osteoarthritis, rheumatoid arthritis (RA), lupus, Sjogren's syndrome, gout, scleroderma, infectious arthritis, and juvenile idiopathic arthritis.

Global Rheumatic Disorders Drug Market Outlook
Rheumatic disorders are recognized among the oldest decease. The economic and social burden of these diseases is huge, without improper approaches to management and control of these diseases, the impact is expected to increase as the population grows. The increasing aging population and smoking population and certain occupations which lead to injury and overuse of joints are increasing the prevalence of rheumatic disorders. The Centres for Disease Control and Prevention announced data estimating that 54.4 million U.S. adults suffer from arthritis - equating to about 25% of the population. Ongoing research on new biologic therapies is anticipated to spur the growth by 2026. Lack of arthritis awareness in a rural region and alternative therapies is seen to have a negative influence on the growth of the market.

Global Rheumatic Disorders Drug Market Competitive Landscape
The "Global Rheumatic Disorders Drug Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, Roche, Eli Lilly, ChemoCentryx and Corbus Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL RHEUMATIC DISORDERS DRUG MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL RHEUMATIC DISORDERS DRUG MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL RHEUMATIC DISORDERS DRUG MARKET, BY MEDICATION
5.1. Overview
5.2. Nonsteroidal anti-inflammatory medications.
5.3. Disease-modifying antirheumatic medications (DMARDs)
5.4. Corticosteroids
5.5. Biologics
5.6. Other

6. GLOBAL RHEUMATIC DISORDERS DRUG MARKET, BY APPLICATION
6.1. Overview
6.2. Rheumatoid Arthritis
6.3. Osteoarthritis
6.4. Osteoporosis
6.5. Systemic Lupus Erythematosus
6.6. Psoriatic Arthritis
6.7. Others

7. GLOBAL RHEUMATIC DISORDERS DRUG MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
8. GLOBAL RHEUMATIC DISORDERS DRUG MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. AbbVie
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Amgen
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Johnson & Johnson
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Novartis
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Pfizer
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Roche
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Eli Lilly
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. ChemoCentryx
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments

9.9. Corbus Pharmaceuticals
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments

9.10. Selecta Biosciences
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments

10. Appendix
10.1. Related Reports

Global Sexually Transmitted Disease (STD ) Drug Market Research Report 2019-2023

Published Date : Oct 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Sexually Transmitted Disease (STD ) Drug Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on t...

Global Natalizumab Drug Market Research Report 2019-2023

Published Date : Oct 2019

Tysabri (natalizumab) is amonoclonal antibodyused in to treat relapsing forms of multiple sclerosis. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Natalizumab Drug Report by Material, Application, and Geography - Glo...

Global Drugs for Musculoskeletal Disorders Market Research Report 2019-2023

Published Date : Oct 2019

Musculoskeletal Disordersor MSDs are injuries anddisordersthat affect the human body's movement ormusculoskeletalsystem (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). In the context of China-US trade war and global economic volatility and uncertainty, it will have a big infl...

Global Drug Refrigerator Market Research Report 2019-2023

Published Date : Oct 2019

A pharmacy refrigerator is an enclosed space with a constantly maintained cold temperature. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Drug Refrigerator Report by Material, Application, and Geography - Global Fore...

Global Drug Refrigerator Box Market Research Report 2019-2023

Published Date : Oct 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Drug Refrigerator Box Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major re...

Global Androgenic Alopecia Drug Market Research Report 2019-2023

Published Date : Sep 2019

Androgenetic alopecia is a common form of hair loss in both men and women. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Androgenic Alopecia Drug Report by Material, Application, and Geography - Global Forecast to 20...

Pulmonary Drug Delivery Systems Market

Published Date : Aug 2019

Pulmonary Drug Delivery Systems Market Size And Forecast According to Verified Market Research, the global pulmonary drug delivery systems market was valued at USD 39.97 Billion in 2018 and is projected to reach USD 58.07 Billion by 2026, growing at a CAGR of 4.8% from 2019 to 2026. The...

Pet Veterinary Drug Market

Published Date : Aug 2019

What is Pet Veterinary Drug? Pet veterinary drug is the category of medicine that deals with the prevention, disorder, and injury in animals and diagnosis and treatment of disease. Among pet veterinary drugs some are similar to human drugs, with development have created a number of specialties...

Global Oxcarbazepine Drug Market Research Report 2019-2023

Published Date : Sep 2019

Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Oxcarbazepine Drug Report by Material, Application, and Geography - Global Fore...

Global Antihemophilic Factor Drug Market Research Report 2019-2023

Published Date : Sep 2019

Antihemophilic Factor Drug is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Antihemophilic Factor Drug Report by ...

 

Select License :

  • Single User : $3950
  • Multiple User : $4750
  • Corporate User : $6750

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.